首页> 外文期刊>Antibiotiques: Journal des Agents Anti-Infectieux >Importance of viral load in hepatitis C
【24h】

Importance of viral load in hepatitis C

机译:丙型肝炎病毒载量的重要性

获取原文
获取原文并翻译 | 示例
       

摘要

This review analyses the usefulness of HCV RNA measurements (viral load) in patients with chronic hepatitis C.HCV infects 2-3% of the world population.It is a RNA virus,classified into at least 11 genotypes and 100 subtypes.In an HCV infected patient,HCV exists as a mixture of genetically distinct viral variants or quasi-species.Several commercial assays are able to quantify HCV RNA including branched DNA technology (signal amplification,Bayer Diagnostics~R),PCR (Roche Diagnostics~R),NASBA (Biomerieux~R),TMA (Chiron~R) and more recently real time PCR.Measurement of HCV viral load is useful in different situations.Treatment of chronic hepatitis C using Interferon-based regimens have been increasingly effective during the last decade,with about half of the patients who will eradicate the virus,identified by a sustained virological response or SVR using the Pegylated-Interferon (PEG-IFN) combined to Ribavirin.Today,RNA detection and quantification are the only systems for pre-therapeutic and therapeutic follow-up of HCV-infected persons undergoing treatment.Measures of HCV RNA before and at 12 weeks of treatment are used to determine early decrease of viral load during treatment.A 2 log HCV RNA variation is considered as a reference to manage treatment for HCV-infected persons,and patients with no significant decrease of viral load may stop treatment.Recent studies have showed that earlier viral load measurement (after 4 weeks of treatment) is also able to predict the long term response.Viral load measurement is also used to assess the infectiveness,ie.after blood exposure or to evaluate the risk of HCV transmission from a HCV infected mother to her baby.
机译:这篇综述分析了HCV RNA测量(病毒载量)在慢性丙型肝炎患者中的有用性.HCV感染了全世界2-3%的人口。它是一种RNA病毒,至少分为11个基因型和100个亚型。受感染的患者,HCV以遗传上不同的病毒变体或准种的混合物形式存在。几种商业化的测定方法都能够定量HCV RNA,包括分支DNA技术(信号放大,Bayer Diagnostics〜R),PCR(Roche Diagnostics〜R),NASBA (Biomerieux〜R),TMA(Chiron〜R)和最近的实时PCR。在不同情况下测量HCV病毒载量是有用的。在过去十年中,使用基于干扰素的方案治疗慢性丙型肝炎越来越有效。约有一半将消灭病毒的患者通过持续病毒学应答或使用聚乙二醇干扰素(PEG-IFN)与利巴韦林联用的SVR进行鉴定。今天,RNA检测和定量是治疗前唯一的系统治疗前和治疗12周时的HCV RNA测量值可用于确定治疗期间病毒载量的早期下降.2 log log HCV RNA变异被认为是管理治疗的参考对于HCV感染者,病毒载量没有明显下降的患者可能会停止治疗。最近的研究表明,较早的病毒载量测量(治疗4周后)也能够预测长期反应。用于评估感染性,即在接触血液后或评估从HCV感染的母亲到婴儿传播HCV的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号